Trump nominee Tom Price sworn in as new US Secretary of Health and Human Services

12 February 2017

On Friday, Dr Tom Price was sworn in as the new US Secretary of Health and Human Services.

This follows the US Senate vote to confirm Representative Price as the top US healthcare official, putting a determined opponent of the Affordable Care Act (commonly referred to as Obamacare) in position to help President Donald Trump dismantle the healthcare law.

Ahead of the vote, US lawmakers challenged the nomination of Dr Price for conflicts of interest and possible insider trading, much of which involved the pharmaceutical and health care sectors that he oversees as chair of the US House of Representatives Budget Committee and as a member of the House Ways and Means Subcommittee on Health.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK